Clinical Trials Directory

Trials / Completed

CompletedNCT02249104

A Treatment Regimen for Student Athletes With Mild to Moderate Acne Vulgaris

Epiduo® (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% Pump, Cetaphil® DermaControl™ Moisturizer SPF 30, and Cetaphil® DermaControl™ Foam Wash Regimen in Student Athletes With Mild to Moderate Acne Vulgaris

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
28 (actual)
Sponsor
Galderma R&D · Industry
Sex
All
Age
12 Years
Healthy volunteers
Not accepted

Summary

The goal of this study is to evaluate a complete topical acne regimen consisting of a prescription acne medication (Epiduo® Gel) and an acne-specific cleanser (Cetaphil® DermaControl™ Foam Wash) and moisturizer with sunscreen (Cetaphil® DermaControl™ Moisturizer SPF 30) for safety, efficacy and patient satisfaction in student athletes with acne vulgaris.

Detailed description

The overall purpose of this study was to demonstrate lesion count reduction from baseline, subject satisfaction, and compliance with a regimen of adapalene BPO used in conjunction with a foam wash and moisturizer with sunscreen in student athletes. The study hypothesis was that this regimen would reduce total lesion count (inflammatory and noninflammatory) relative to baseline. The objective of this study was to evaluate the change in lesion count (total, inflammatory, and noninflammatory) in subjects using the CoMMPlete regimen.

Conditions

Interventions

TypeNameDescription
DRUGAdapalene/benzoyl peroxide gel, 0.1%/2.5%Topical AV therapy
OTHERCetaphil Acne RegimenCleanse, Moisturize, and Protect

Timeline

Start date
2014-08-01
Primary completion
2015-02-01
Completion
2015-02-01
First posted
2014-09-25
Last updated
2022-08-23
Results posted
2016-05-26

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02249104. Inclusion in this directory is not an endorsement.

A Treatment Regimen for Student Athletes With Mild to Moderate Acne Vulgaris (NCT02249104) · Clinical Trials Directory